✦ LIBER ✦

The efficacy and safety of leflunomide therapy in lupus nephritis by repeat kidney biopsy

✍ Scribed by F. S. Zhang; Y. K. Nie; X. M. Jin; H. M. Yu; Y. N. Li; Y. Sun

Publisher: Springer
Year: 2009
Tongue: English
Weight: 218 KB
Volume: 29
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-009-0861-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of tacrolimus for in

Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis

✍ Satoshi Takahashi; Keiju Hiromura; Noriyuki Sakurai; Takayuki Matsumoto; Hidekaz 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 211 KB

Long-term prognosis in lupus nephritis:

Long-term prognosis in lupus nephritis: relation to the renal biopsy data, therapy, and grade of remission

✍ Tokano, Yoshiaki ;Amano, Hirofumi ;Takai, Syhei ;Yamanaka, Kenjiro ;Sugawara, Ma 📂 Article 📅 1999 🏛 Informa UK (Informa Healthcare) 🌐 English ⚖ 578 KB

Efficacy of low-dose versus high-dose cy

Efficacy of low-dose versus high-dose cyclophosphamide in lupus nephritis: Comment on the article by Houssiau et al

✍ Joel A. Block 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

In a recent article (1), Chapman et al described a genetic linkage of primary hip osteoarthritis (OA) with restricted areas on chromosome 11q. This is an elegant study, which may well provide important new insights into hip OA. Nonetheless, I would like to raise concerns about their choice of patien

In lupus nephritis, the benefit of ritux

In lupus nephritis, the benefit of rituximab monotherapy, as opposed to rituximab plus cyclophosphamide combination therapy, remains uncertain: Comment on the article by Sfikakis et al

✍ Ronald van Vollenhoven; Iva Gunnarsson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views